Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21878454 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo

Indicates status has not been verified in more than two years